Streptococcus pneumoniae and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis?

Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clini...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical microbiology Vol. 66; no. 8; pp. 1253 - 1256
Main Authors Brown, Lauren April, Mitchell, Andrea M, Mitchell, Tim J
Format Journal Article
LanguageEnglish
Published England 01.08.2017
Online AccessGet full text

Cover

Loading…
Abstract Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clinical guidelines referring to the treatment of invasive pneumococcal infection. NICE clinical guidelines suggest the use of lytic β-lactam antibiotic regimens for the management of community-acquired pneumonia and bacterial meningitis; infections for which S. pneumoniae is a likely causative organism. Lytic antibiotics have been shown to increase the release of pneumolysin (the highly inflammatory and damaging toxin of the pneumococcus), thus theoretically increasing host damage, which may lead to a decline of clinical outcomes in vulnerable patients. In light of this information, should the use of non-lytic antibiotics, such as quinolones, rifamycins and macrolides, be considered for the treatment of invasive pneumococcal disease?
AbstractList Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clinical guidelines referring to the treatment of invasive pneumococcal infection. NICE clinical guidelines suggest the use of lytic β-lactam antibiotic regimens for the management of community-acquired pneumonia and bacterial meningitis; infections for which S. pneumoniae is a likely causative organism. Lytic antibiotics have been shown to increase the release of pneumolysin (the highly inflammatory and damaging toxin of the pneumococcus), thus theoretically increasing host damage, which may lead to a decline of clinical outcomes in vulnerable patients. In light of this information, should the use of non-lytic antibiotics, such as quinolones, rifamycins and macrolides, be considered for the treatment of invasive pneumococcal disease?
Author Mitchell, Tim J
Brown, Lauren April
Mitchell, Andrea M
Author_xml – sequence: 1
  givenname: Lauren April
  surname: Brown
  fullname: Brown, Lauren April
  organization: 1​iBMedSci, The University of Birmingham, Birmingham, UK
– sequence: 2
  givenname: Andrea M
  surname: Mitchell
  fullname: Mitchell, Andrea M
  organization: 2​Pneumococcal Research Group, Institute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK
– sequence: 3
  givenname: Tim J
  surname: Mitchell
  fullname: Mitchell, Tim J
  organization: 2​Pneumococcal Research Group, Institute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28792379$$D View this record in MEDLINE/PubMed
BookMark eNo9kEtLxDAUhYMoOj52riVLF3bMczJxIzL4AsGFui5pckcztE1NUmX-gL_bDh1d3cPl4xz4DtFuG1pA6JSSKSVaX66aZkqmhBAp5A6aUKF4IWdC7KIJIYwVbEblATpMaUUIVZzrfXTA5kozrvQE_bzkCF0ONljbJ9y10Deh9QawaR2u19nbIWVf-bCJ-QOi6dZX2ETA3wPknG_fsW9TX2ecw5BWfVxj18fx_2WS_4Jt72bE1Nj5BCaNCwm65NP1MdpbmjrByfYeobe729fFQ_H0fP-4uHkqLNcyFzM7p8ToSjs-YwKIYYbSiitLBQfmCLdMzJUEwQ2Xdl5pqJRcGi6cZVYsgR-h87G3i-Gzh5TLxicLdW1aCH0qqWZK6sGMGtCLEbUxpBRhWXbRNyauS0rKjflyMF-ScjQ_4Gfb5r5qwP3Df6r5L7Rug_k
CitedBy_id crossref_primary_10_1021_acsinfecdis_9b00344
crossref_primary_10_3390_molecules24162902
crossref_primary_10_1128_Spectrum_00318_21
crossref_primary_10_3390_metabo11120821
crossref_primary_10_1007_s40259_023_00580_y
crossref_primary_10_1186_s12879_020_4901_7
crossref_primary_10_12688_f1000research_14226_1
crossref_primary_10_1016_j_ccm_2018_08_008
crossref_primary_10_1021_acs_jmedchem_0c00520
crossref_primary_10_1097_MCP_0000000000000571
crossref_primary_10_1016_j_heliyon_2022_e12620
Cites_doi 10.1371/journal.pone.0092355
10.1186/1472-6750-14-16
10.1111/jth.12047
10.4103/0970-2113.99248
10.1186/s12866-016-0881-6
10.1136/thx.2009.121434
10.1002/9783527659685
10.1159/000220828
10.1128/JB.00114-12
10.1183/09059180.00008911
10.4049/jimmunol.1401624
10.1136/adc.2010.191718
10.1111/j.1365-2958.1991.tb00812.x
10.3855/jidc.4711
10.1128/CMR.00018-12
10.2217/17460913.3.4.397
10.4161/viru.27135
10.1111/j.1471-4159.2004.02837.x
10.1086/511159
10.1084/jem.20.4.363
10.1074/jbc.M501236200
10.1007/s00249-015-1106-x
10.12688/f1000research.7657.1
10.1186/s13054-015-1021-7
10.1128/AAC.47.8.2649-2654.2003
ContentType Journal Article
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1099/jmm.0.000545
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1473-5644
EndPage 1256
ExternalDocumentID 10_1099_jmm_0_000545
28792379
Genre Journal Article
GroupedDBID ---
-~X
18M
2WC
4.4
53G
5GY
5RE
5RS
AAYEP
ABOCM
ACGFO
ACPEE
ADBBV
ADCDP
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C45
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
L7B
M5~
NPM
OBC
OBS
OEB
OFXIZ
OK1
OVD
OWW
P0W
P2P
RGM
TEORI
TR2
VVN
W8F
WOQ
YFH
YQY
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c395t-6c810a9b9d3624e0a2a11b37c143e2d03c24875e43a35c8b9eb75fa34dc2c4fe3
ISSN 0022-2615
IngestDate Fri Oct 25 11:37:37 EDT 2024
Fri Dec 06 01:10:47 EST 2024
Tue Oct 15 23:57:10 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c395t-6c810a9b9d3624e0a2a11b37c143e2d03c24875e43a35c8b9eb75fa34dc2c4fe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1099/jmm.0.000545
PMID 28792379
PQID 1927593797
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1927593797
crossref_primary_10_1099_jmm_0_000545
pubmed_primary_28792379
PublicationCentury 2000
PublicationDate 2017-08-01
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of medical microbiology
PublicationTitleAlternate J Med Microbiol
PublicationYear 2017
References (R5) 2016
Gualerzi (R24) 2013
R23
R22
R25
R27
R26
(R2) 2016
(R19) 2014
R28
(R7) 2013
(R21) 2015
R3
R4
R6
R8
R9
R30
R10
R32
R31
R12
R11
R33
R14
R13
R16
R15
Horaud (R1) 2013
R18
R17
Gupta (R20) 2012; 29
Lobanovska (R29) 2017; 90
References_xml – ident: R16
  doi: 10.1371/journal.pone.0092355
– ident: R9
  doi: 10.1186/1472-6750-14-16
– ident: R17
  doi: 10.1111/jth.12047
– volume: 29
  start-page: S27
  year: 2012
  ident: R20
  article-title: Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults
  publication-title: Lung Ind
  doi: 10.4103/0970-2113.99248
  contributor:
    fullname: Gupta
– year: 2015
  ident: R21
  article-title: Bacterial meningitis and meningococcal septicaemia
– ident: R12
  doi: 10.1186/s12866-016-0881-6
– ident: R18
  doi: 10.1136/thx.2009.121434
– year: 2013
  ident: R24
  article-title: Antibiotics: targets, mechanisms and resistance
  doi: 10.1002/9783527659685
  contributor:
    fullname: Gualerzi
– start-page: 939
  volume-title: Streptococci and the Host
  year: 2013
  ident: R1
  contributor:
    fullname: Horaud
– ident: R31
  doi: 10.1159/000220828
– ident: R10
  doi: 10.1128/JB.00114-12
– ident: R3
  doi: 10.1183/09059180.00008911
– ident: R15
  doi: 10.4049/jimmunol.1401624
– ident: R23
  doi: 10.1136/adc.2010.191718
– ident: R14
  doi: 10.1111/j.1365-2958.1991.tb00812.x
– ident: R33
  doi: 10.3855/jidc.4711
– volume: 90
  start-page: 135
  year: 2017
  ident: R29
  article-title: Penicillin's discovery and antibiotic resistance lessons for the future?
  publication-title: Yale J Biol Med
  contributor:
    fullname: Lobanovska
– ident: R6
  doi: 10.1128/CMR.00018-12
– ident: R28
  doi: 10.2217/17460913.3.4.397
– ident: R4
  doi: 10.4161/viru.27135
– ident: R27
  doi: 10.1111/j.1471-4159.2004.02837.x
– ident: R22
  doi: 10.1086/511159
– year: 2013
  ident: R7
– year: 2016
  ident: R5
  article-title: Sepsis: recognition, diagnosis and early management. NICE Guideline
– ident: R11
  doi: 10.1084/jem.20.4.363
– ident: R30
  doi: 10.1074/jbc.M501236200
– year: 2016
  ident: R2
  article-title: Pneumococcal disease
– ident: R13
  doi: 10.1007/s00249-015-1106-x
– year: 2014
  ident: R19
  article-title: Pneumonia in adults: diagnosis and management
– ident: R25
  doi: 10.12688/f1000research.7657.1
– ident: R32
  doi: 10.1186/s13054-015-1021-7
– ident: R26
  doi: 10.1128/AAC.47.8.2649-2654.2003
– ident: R8
SSID ssj0017339
Score 2.3038206
Snippet Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 1253
Title Streptococcus pneumoniae and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis?
URI https://www.ncbi.nlm.nih.gov/pubmed/28792379
https://search.proquest.com/docview/1927593797
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WiuKLaL2tN0bQJ0lNMjObji8iohZhfWphnwxzC0SaC01iqT_A3-2ZSzZpa0F9CSEzmwNzvj35zpzLIPSSxdoYIWQkeGEiKuIskiqVkS6UZgUjWSqto7j-ujo4ol82bLNYfJtlLQ293FM__1hX8j9ahWegV1sl-w-a3b4UHsA96BeuoGG4_pWObUi57RuwaWroXre1GUB0KXxE4PjM92K1RSGNvfWlVq7Dk033OoVpOpS0dMNxb1loWX-HNR5rF8v6h3DZ7f7NVswU0nEyOtN2ZXchOXDGcasQBqrKqd_TpQ0AW5ptauDDJ1O6x7rsXYrqNudSTNu28zGAWghshZ0L-BqOeXPw4fHWlmYkYivfAPKSLQfuam15Ve3Z7Duglmw-DRarrZxewecDluqPpLnQO3scuoau20aJ9myFz5ttClCSEcJDMQQIezMXZZtEhx-fZyxXuCGOjhzeQbfDGuP3HhR30cLUu-iGP1n0bBfdXIeciXvo1zmU4AklGDSIHUrwhBIcUPIWA0bwKUxyGMEeI7hvsMcI9hjBI0bwHCM4YMRJ8Bh5dx8dffp4-OEgCqdvRIpw1kcrtZ_EgkuugeNQE4tUJIkkmQKGbVIdE5VaZ9dQIghT-5IbmbFCEKpVqmhhyAO0Uze1eYSwhH99qlkcCwMOgpYCTECRGM4p5ZLEYolejSuct77JSu6TI3gOSsltB1urlCV6MS5_DlbQhrZEbZqhy8FPyRgwbZ4t0UOvl-2bRj0-vnLkCbo14fMp2ulPBvMMuGYvnzvA_AZkwIbo
link.rule.ids 314,780,784,27924,27925
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Streptococcus+pneumoniae+and+lytic+antibiotic+therapy%3A+are+we+adding+insult+to+injury+during+invasive+pneumococcal+disease+and+sepsis%3F&rft.jtitle=Journal+of+medical+microbiology&rft.au=Brown%2C+Lauren+April&rft.au=Mitchell%2C+Andrea+M&rft.au=Mitchell%2C+Tim+J&rft.date=2017-08-01&rft.eissn=1473-5644&rft_id=info:doi/10.1099%2Fjmm.0.000545&rft_id=info%3Apmid%2F28792379&rft.externalDocID=28792379
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2615&client=summon